iScience, 2023 · DOI: https://doi.org/10.1016/j.isci.2022.105725 · Published: January 20, 2023
Malaria parasites are becoming resistant to artemisinin, a key drug. This study found that resistant parasites slow their growth in the early ring stage. The researchers created artemisinin-resistant parasites and studied their metabolism. They discovered changes in energy production and amino acid usage. By manipulating these metabolic pathways, the researchers could alter the parasites' resistance to artemisinin, suggesting new drug targets.
Identifies metabolic pathways as potential targets for novel antimalarial drugs.
Provides insights into the metabolic adaptations that contribute to artemisinin resistance in malaria parasites.
Suggests that targeting metabolic plasticity could be a strategy to overcome artemisinin resistance.